Full-Time

Senior Medical Science Liaison

Posted on 7/31/2024

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell receptors for diagnostics

Biotechnology
Healthcare

Compensation Overview

$181.5k - $272.3kAnnually

+ Equity Grant + Bonus

Senior

No H1B Sponsorship

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • MD, PharmD, or PhD preferred. Advanced professional degree (NP, PA, RPh, etc.) may be considered for candidates with significant clinical hematology/oncology experience.
  • 4+ years relevant industry and/or hematology/oncology disease experience required.
  • 2+ years MSL experience preferred.
  • In-depth scientific and/or therapeutic knowledge required.
  • Existing relationships with key opinion leaders and affiliated institutions required.
  • Demonstrated understanding of clinical trial management.
  • Working knowledge of regulatory guidance and reporting requirements.
  • Exceptional organizational and time management skills.
  • Strong presentations skills including excellent verbal and written communication.
  • Strong interpersonal skills and demonstrated ability to work effectively in a cross functional team.
  • A self-starter with a results-driven mentality and positive attitude.
  • Computer proficiency in Excel, Word, PowerPoint, and Adobe.
Responsibilities
  • Develop and maintain significant scientific relationships with hematology Key Opinion Leaders
  • Focus to include educating physicians and other healthcare providers in the community oncology setting on disease state awareness, next generation sequencing minimal residual disease, and clinical utility through 1:1 discussions/presentations, roundtable discussions, or formal presentations
  • Serve as a trusted clinical education/information subject matter expert to HCPs within academic and community institutions to help them better understand how MRD can be implemented in the patient’s clinical journey
  • Provide internal teams with feedback and insights from interactions and discussions with HCPs
  • Coordinate local and regional investigator initiated research (IIR)
  • Manage IIR milestones and objectives
  • Report on scientific sessions at congresses
  • Respond to and document unsolicited requests for scientific information
  • Provide clinical input and assist with training to internal functions as requested
  • Provide Advisory Board content development support
  • Work closely with other field-based teams and HQ staff to respond to information requests in a timely manner
  • Address complex scientific/clinical topics and projects with minimal/no oversight
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand the immune response to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies generates revenue through partnerships with pharmaceutical companies, licensing their technology, and offering diagnostic services. Their goal is to advance healthcare by leveraging immune system data to develop better therapies and diagnostic tools.

Company Stage

IPO

Total Funding

$395.8M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

-11%

2 year growth

-15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Adaptive Biotechnologies' partnerships with pharmaceutical companies and healthcare providers offer significant growth opportunities and revenue streams.
  • Winning the Workplace of the Year Award highlights their strong company culture and employee satisfaction, making it an attractive place to work.
  • Their collaboration with BeiGene on minimal residual disease measurement could lead to groundbreaking advancements in cancer treatment.

What critics are saying

  • The departure of key board members like Kevin Conroy and Leslie Trigg could lead to strategic instability.
  • The highly competitive biotechnology sector requires continuous innovation to maintain market position.

What makes Adaptive Biotechnologies unique

  • Adaptive Biotechnologies leverages the genetic information of immune cell receptors to develop advanced diagnostic tools and treatments, setting it apart from traditional biotech firms.
  • Their ImmuneRACE study, focusing on COVID-19 immune response, showcases their commitment to addressing current global health challenges.
  • The integration of their clonoSEQ® assay with Epic systems enhances their diagnostic capabilities, providing a seamless experience for healthcare providers.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE